Laser plus medicine for skin sores from leishmaniasis
Part of Infections, Skin clinical trials.
This trial tests whether adding a special laser treatment (fractional CO₂ laser) to the standard injected medicine (Glucantime) helps heal skin sores from a parasite infection better than the medicine alone. It may offer a more effective way to clear the sores and improve healing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old.
- You have been diagnosed with cutaneous leishmaniasis (a skin infection causing sores).
- You have at least one skin sore that can be treated.
- You have not already had treatment for these sores.
- Your sores are not within about 2 cm of your eyelid or lip, and you are not pregnant or breastfeeding.
- You are generally healthy and willing to attend follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares different drugs to find the best one for treating cutaneous leishmaniasis, a skin infection that causes sores. You might get one of several treatments, and the goal is to see which works best and is safest for patients like you.
This study tests whether adding a special medicine (an antimicrobial adjuvant) to the standard treatment for complicated skin sores caused by leishmaniasis can improve healing. It is for people in Ethiopia with sores that are large, many, or in sensitive areas.
This study tests two new oral medicines (called LXE408) against an existing oral treatment (miltefosine) for people with a first episode of localized cutaneous leishmaniasis (skin sores caused by a parasite). The goal is to see if the new medicines are safe and work better at healing the sores.
This study tests whether applying a heat pack to skin sores caused by cutaneous leishmaniasis can help treat them. It's for people who cannot take the standard medication or prefer a non-drug option.
This study tests a gel containing miltefosine (a medicine) applied directly to the skin sores caused by cutaneous leishmaniasis. The goal is to see if the gel is safe and works to clear the sores.
This study tests if using heat therapy (thermotherapy) in local clinics is a good way to treat skin sores caused by leishmaniasis. It may be an option for people with a few small sores not on the face or near sensitive areas.
Hear when a new Cutaneous Leishminiasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.